Felnagle Elizabeth A, Jackson Emily E, Chan Yolande A, Podevels Angela M, Berti Andrew D, McMahon Matthew D, Thomas Michael G
Department of Bacteriology, University of Wisconsin-Madison, Madison, Wisconsin 53706, USA.
Mol Pharm. 2008 Mar-Apr;5(2):191-211. doi: 10.1021/mp700137g. Epub 2008 Jan 25.
Natural products biosynthesized wholly or in part by nonribosomal peptide synthetases (NRPSs) are some of the most important drugs currently used clinically for the treatment of a variety of diseases. Since the initial research into NRPSs in the early 1960s, we have gained considerable insights into the mechanism by which these enzymes assemble these natural products. This review will present a brief history of how the basic mechanistic steps of NRPSs were initially deciphered and how this information has led us to understand how nature modified these systems to generate the enormous structural diversity seen in nonribosomal peptides. This review will also briefly discuss how drug development and discovery are being influenced by what we have learned from nature about nonribosomal peptide biosynthesis.
完全或部分由非核糖体肽合成酶(NRPSs)生物合成的天然产物是目前临床上用于治疗多种疾病的一些最重要的药物。自20世纪60年代初对NRPSs进行初步研究以来,我们对这些酶组装这些天然产物的机制有了相当深入的了解。本综述将简要介绍NRPSs基本机制步骤最初是如何被破译的,以及这些信息如何使我们理解自然界如何改造这些系统以产生非核糖体肽中所见的巨大结构多样性。本综述还将简要讨论我们从自然界了解到的非核糖体肽生物合成知识如何影响药物开发和发现。